Coming Soon: Conexiant’s news site is becoming MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more.
Ophthalmology
Partner With Us
Advertisement
Conexiant chevron_right Ophthalmology chevron_right DOJ Announces First Health Care Company Declination
FDA & Government News

DOJ Announces First Health Care Company Declination

Campus Eye avoided prosecution after voluntarily disclosing misconduct, cooperating with investigators, and remediating the wrongdoing.

MDSpire News

Clinical Scorecard: DOJ Announces First Health Care Company Declination

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: DOJ Announces First Health Care Company Declination
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationHealth care companies and executives involved in misconduct related to health care fraud.
Care SettingCare setting described in the source article.

Key Highlights

  • DOJ declined to prosecute Campus Eye Management Holdings LLC after voluntary disclosure and cooperation.
  • Campus Eye agreed to repay $1 million to victims as part of the resolution.
  • E. Bruce DiDonato indicted on multiple counts related to health care fraud and kickback schemes.
  • The declination reflects the DOJ's Corporate Enforcement and Voluntary Self-Disclosure Policy.
  • If convicted, DiDonato faces a potential maximum of 45 years in prison.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • Voluntary disclosure of misconduct can lead to declination of prosecution.
          • Cooperation with investigations is critical for favorable outcomes.

          Related Resources & Content

          Daily News

          Stay up to date with the latest clinical headlines and other information tailored to your specialty.